For AJ Jasper, drugs hailed as miracles have proven nothing short of a curse. In 2024, a hard-won truce between Jasper and the anorexia he had battled, on and off, since childhood collapsed, sending h...
10.15.2026 Cnn.com and 2 sites
GLP-1 medications for weight loss and diabetes appear to slow the body’s aging processes, a sign that the blockbuster drugs could ultimately help people live longer. The idea that these medications ma...
10.13.2026 yahoo.com , cnn.com and 40 sites
US inspectors documented egregious conditions at two Chinese factories making key components for compounded GLP-1 drugs popular in America, including black mold on equipment and “gross contamination” ...
10.15.2026 yahoo.com , bloomberg.com , nypost.com and 1 sitesBy Patrick Wingrove LONDON, Oct 15 (Reuters) - AstraZeneca has teamed up with artificial intelligence biotech company insitro to discover and develop new treatments for difficult to treat liver and h...
10.15.2026 reuters.com , channelnewsasia.com , business-standard.com and 15 sites
ZURICH, Oct 13 (Reuters) - Swiss drugmaker Roche entered a licensing agreement worth up to $1. 16 billion with Rona Therapeutics for its investigational obesity drug candidate, the Chinese biotech firm said on Tuesday. Roche has been racing to break into the obesity drug market dominated by Eli Lilly and Novo Nordisk. • With the deal, Rona Therapeutics is set to receive an upfront payment of $100 million and is eligible to receive up to $1. 06 billion in potential milestone payments, a...
10.13.2026 msn.com , yahoo.com , reuters.com and 5 sitesNEW YORK: The S&P 500 ended higher on Thursday, springing back from early losses as investors concerned about AI stocks shifted into Eli Lilly, UnitedHealth and other healthcare and consumer stocks. S...
10.15.2026 indiatimes.com , freemalaysiatoday.com , thestar.com.my and 6 sites
FRANKFURT, Oct 19 (Reuters) – Swiss drugmaker Roche is reviewing all future investments in Germany over healthcare cost-cutting policies, the company’s Germany chief said in an interview with newspape...
10.19.2026 reuters.com , yahoo.com , aol.com and 6 sites
The Food and Drug Administration received reports in recent months that two people died after taking bootleg versions of an experimental weight-loss drug, according to documents reviewed by CBS News. ...
10.13.2026 aol.com , msn.com , cbsnews.com and 1 sites
SteelPeak Wealth LLC raised its position in shares of Arista Networks, Inc. ( NYSE: ANET – Free Report ) by 93. 4% in the 3rd quarter, according to the company in its most recent Form 13F filing with ...
10.17.2026 Themarketsdaily.com and 159 sitesIt’s an epic battle today between Novo Nordisk and Eli Lilly in the high-profile and rapidly growing diabetes and obesity drug market. Both companies have large global capability centres (GCCs) in India that are becoming increasingly vital in this ba...
10.14.2026 Indiatimes.com